Detox and dependence
Separate an urgent withdrawal or substance-use concern from a broader hope for insight. Medical stability and assessment may need to come first.
A practical decision framework
Decision Workbook
A structured way to clarify goals, name risk factors, and prepare better questions when comparing ibogaine and ayahuasca.
This workbook is for reflection and informed discussion, not a substitute for medical, mental-health, or legal advice.
01 / Start with the purpose
Name the question before comparing the options.
A useful comparison starts with the outcome a person is actually seeking. “Which is better?” hides important differences in goal, medical context, setting, and legal exposure.
Write one sentence that is specific enough to test: “I am trying to understand options related to substance dependence,” “I am looking for psychotherapy-oriented reflection,” or “I am considering spiritual work.” These are not interchangeable aims, and no compound is a simple answer to any of them.
Psychotherapy
Clarify whether you are seeking a structured therapeutic relationship, a personal experience, or a way to explore persistent symptoms.
Spiritual work
Consider the meaning, community, consent practices, and cultural setting you expect—not only the substance itself.
For a broader orientation before using this workbook, begin with the comparison framework available through Quiet Harbor 51, then return to the questions that apply to your circumstances.
02 / A short printable pause
Before any decision, put these facts in one place.
Copy this checklist into a notebook or print it. The point is not to qualify yourself for an experience; it is to make uncertainty visible and to identify questions that require qualified professional input.
- My immediate goal and what would count as a realistic outcome.
- My current medicines, supplements, substance use, and recent changes.
- My known heart, seizure, liver, psychiatric, or family-health history.
- My support plan before and after any decision, including transport and follow-up care.
- What I do not know yet about legality, screening, emergency planning, and consent.
03 / Map risk, not just hopes
A meaningful risk map is more than a diagnosis.
Personal risk can involve health history, medication interactions, current stability, the setting, and whether a provider’s claims can be independently checked. It also includes the pressure someone may feel to decide quickly.
Ibogaine has been associated with potentially serious cardiac concerns, including effects on heart rhythm. A general overview of the long QT syndrome concept can help explain why heart-history questions and clinical screening are not minor details.
Ayahuasca commonly contains compounds that act as monoamine oxidase inhibitors, which can make medication disclosure especially important. The National Institute of Mental Health’s overview of mental health medications is a useful reminder not to stop or change prescribed medication without speaking to the clinician who manages it.
Physical health
List cardiac history, fainting, seizures, liver concerns, pregnancy, and any other condition that may affect safety or the ability to receive emergency care.
Medication and substance context
Write medications, supplements, alcohol and other substance use, and timing. “Natural” does not mean interaction-free.
Mental health and support
Include current symptoms, sleep disruption, past psychosis or mania, family history, and whether trusted support and follow-up are available.
Setting and accountability
Ask what screening occurs, who responds in an emergency, what records are kept, and how consent, boundaries, and aftercare are handled.
“A reason to slow down is not a failure of resolve. It may be the most useful result of the workbook.”
04 / Test the framework against reality
Two scenarios for slowing down the comparison.
These examples are not individualized recommendations. They show how a decision can change when relevant risk factors are placed beside a stated goal.
Scenario A
Opioid dependence and cardiac history
A person is focused on opioid dependence and has a history of heart symptoms or prior cardiac findings. The central issue is not choosing between two experiences based on a promise of rapid change. It is recognizing that cardiac history, withdrawal management, current substance use, and access to appropriate medical evaluation are decision-changing facts. This scenario calls for careful assessment by qualified medical professionals rather than a self-directed comparison.
Scenario B
Treatment-resistant depression and SSRI use
A person with persistent depression is taking an SSRI and is considering ayahuasca after other care has not felt sufficient. The decision framework highlights medication interaction questions, symptom stability, current support, and the risk of abruptly changing a prescribed regimen. It also distinguishes understandable hope from evidence of suitability, and points back toward a prescriber or qualified mental-health professional for medication decisions.
05 / Keep the limits in view
Research and legality do not support a shortcut.
Current research on ibogaine and ayahuasca is limited, context-dependent, and not a basis for broad treatment claims. Study settings, screening protocols, participant selection, follow-up, and legal status vary considerably. A promising account or a compelling personal story cannot establish that an option is safe or appropriate for a particular person.
In the United States, ibogaine is listed as a Schedule I controlled substance by the Drug Enforcement Administration’s drug scheduling information. Legal and regulatory context can differ by substance, jurisdiction, and activity; it is worth checking current local rules rather than relying on informal assurances.
For a practical overview of comparative questions and uncertainty, the independent ibogaine treatment information resource in Canada may help readers identify additional points to verify. Questions about how this site approaches evidence and boundaries are also addressed on our approach and principles page.
A deliberate next step
The most useful decision may be to gather better information first.
Return to the workbook after a conversation with qualified professionals, after verifying legal context, or after identifying a risk factor that deserves attention. Careful questions are part of informed consent.